Intellia Therapeutics (NTLA) Change in Account Payables (2015 - 2026)
Intellia Therapeutics (NTLA) reported Change in Account Payables of -$1.4 million for Q1 2026, up 24.02% year-over-year from -$1.1 million in Q1 2025, and down 120.41% on a QoQ basis from $7.0 million in Q4 2025.
Intellia Therapeutics (NTLA) has 12 years of Change in Account Payables data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Change in Account Payables rose 24.02% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 1108.78% YoY) and the FY2025 annual result came in at $6.0 million, down 11.96% from the prior year.
- Change in Account Payables eased to -$1.4 million in Q1 2026 per NTLA's latest filing, from $7.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.0 million in Q4 2025 and bottomed at -$7.7 million in Q3 2023.
- The 5-year median for Change in Account Payables is $750000.0 (2022), against an average of $547352.9.
- Peak annual rise in Change in Account Payables reached 2152.63% in 2023, while the deepest fall reached 374.51% in 2023.
- Tracing NTLA's Change in Account Payables over 5 years: stood at $750000.0 in 2022, then jumped by 425.47% to $3.9 million in 2023, then tumbled by 63.56% to $1.4 million in 2024, then surged by 384.61% to $7.0 million in 2025, then sank by 120.41% to -$1.4 million in 2026.
- Per Business Quant, the three latest NTLA Change in Account Payables figures stand at -$1.4 million (Q1 2026), $7.0 million (Q4 2025), and $3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | 6.96 Mn |
| Dec 31, 2025 | 6.96 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Jun 30, 2025 | -2.56 Mn |
| Jun 30, 2025 | -2.56 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | -5.55 Mn |
| Sep 30, 2024 | -5.55 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 5.57 Mn |
| Mar 31, 2024 | 5.57 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Sep 30, 2023 | -7.71 Mn |
| Sep 30, 2023 | -7.71 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 750,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | -1.62 Mn |
| Sep 30, 2022 | -1.62 Mn |
| Jun 30, 2022 | -3.65 Mn |
| Jun 30, 2022 | -3.65 Mn |
| Mar 31, 2022 | -57,000.00 |
| Mar 31, 2022 | -57,000.00 |
| Dec 31, 2021 | 2.40 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 736,000.00 |
| Sep 30, 2021 | 736,000.00 |
| Jun 30, 2021 | -1.69 Mn |
| Jun 30, 2021 | -1.69 Mn |
| Mar 31, 2021 | -917,000.00 |
| Mar 31, 2021 | -917,000.00 |
| Dec 31, 2020 | 1.62 Mn |
| Dec 31, 2020 | 1.62 Mn |
| Sep 30, 2020 | 7.34 Mn |
| Sep 30, 2020 | 7.34 Mn |
| Jun 30, 2020 | -3.53 Mn |
| Jun 30, 2020 | -3.53 Mn |
| Mar 31, 2020 | -370,000.00 |
| Mar 31, 2020 | -370,000.00 |
| Dec 31, 2019 | -30,000.00 |
| Dec 31, 2019 | -30,000.00 |
| Sep 30, 2019 | 2.20 Mn |
| Sep 30, 2019 | 2.20 Mn |
| Jun 30, 2019 | -1.65 Mn |
| Jun 30, 2019 | -1.65 Mn |
| Mar 31, 2019 | 1.36 Mn |
| Mar 31, 2019 | 1.36 Mn |
| Dec 31, 2018 | 297,000.00 |
| Dec 31, 2018 | 297,000.00 |
| Sep 30, 2018 | 1.53 Mn |
| Sep 30, 2018 | 1.53 Mn |
| Jun 30, 2018 | -1.66 Mn |
| Jun 30, 2018 | -1.66 Mn |
| Mar 31, 2018 | 59,000.00 |
| Mar 31, 2018 | 59,000.00 |
| Dec 31, 2017 | -256,000.00 |
| Dec 31, 2017 | -256,000.00 |
| Sep 30, 2017 | 438,000.00 |
| Sep 30, 2017 | 438,000.00 |
| Jun 30, 2017 | 284,000.00 |
| Jun 30, 2017 | 284,000.00 |
| Mar 31, 2017 | -954,000.00 |
| Mar 31, 2017 | -954,000.00 |
| Dec 31, 2016 | 1.63 Mn |
| Dec 31, 2016 | 1.63 Mn |
| Sep 30, 2016 | 521,000.00 |
| Sep 30, 2016 | 521,000.00 |
| Jun 30, 2016 | -280,000.00 |
| Jun 30, 2016 | -280,000.00 |
| Mar 31, 2016 | -87,000.00 |
| Mar 31, 2016 | -87,000.00 |
| Dec 31, 2015 | -70,000.00 |
| Dec 31, 2015 | -70,000.00 |
| Sep 30, 2015 | -792,000.00 |
| Sep 30, 2015 | -792,000.00 |
| Jun 30, 2015 | 837,000.00 |
| Jun 30, 2015 | 837,000.00 |
| Mar 31, 2015 | 360,000.00 |
| Mar 31, 2015 | 360,000.00 |